P
Remote · United States
Proscia, founded in 2014, builds the AI-native Concentriq digital pathology platform, used in more than 4,000 hospitals and clinics and by 16 of the top 20 pharma companies.
Proscia is a digital pathology company founded in 2014. It builds Concentriq, an AI-native pathology platform that brings machine-learning-driven intelligence to pathologists and researchers, supporting workflows across cancer discovery, diagnosis and treatment.
The platform operates at considerable scale. Concentriq powers more than 12m cases a year across upwards of 4,000 hospitals and clinics worldwide, and is used by 16 of the top 20 pharmaceutical companies. The company sells into several verticals, among them pharmaceuticals and biotech, hospitals and clinical laboratories, oncology and cancer diagnostics, drug discovery and development, and precision medicine.
Technical work spans AI and machine learning, image analysis and pathology informatics, healthcare software and precision medicine. The team is drawn from engineering, science and healthcare, and is organised around problems at the intersection of AI, healthcare and precision medicine, with particular attention to the effect that code and models have on patient care.